Adrenal disease

Safety of Antenatal Predniso(lo)ne and Dexamethasone on Fetal, Neonatal and Childhood Outcomes: A Systematic Review

J Clin Endocrinol MetabPublished Systematic review

Authors' conclusion

Based on the limited evidence found, predniso(lo)ne may have less side effects compared with dexamethasone in short- and long-term outcomes. Current literature shows minimal risk of side effects in the newborn from administration of a prenatal predniso(lo)ne dose of up to 10 mg per day.

Study context

Population
Human studies of long-term antenatal predniso(lo)ne or dexamethasone use, assessing side effects on the child in the fetal period, neonatal phase and childhood; PubMed/MEDLINE and Embase to August 202215 eligible studies + 7 from references
Comparison
Antenatal prednisone vs dexamethasone
Outcome
Side effects on the fetus, newborn and (pre)pubertal child
Methodological detailsSearch of PubMed/MEDLINE and Embase: 328 papers in PubMed and 193 in Embase identified; 15 eligible; 7 added through references
  • Search of PubMed/MEDLINE and Embase: 328 papers in PubMed and 193 in Embase identified; 15 eligible; 7 added through references

Pooled result

As reported in the abstract

Side effects on fetal, neonatal and childhood outcomes
  • Predniso(lo)ne may be associated with lower gestational age
  • Predniso(lo)ne not associated with miscarriages and stillbirths, congenital abnormalities, differences in blood pressure or low blood glucose at birth
  • Predniso(lo)ne not associated with low bone mass, long-term elevated cortisol and cortisone, or high blood pressure at prepubertal age
  • Dexamethasone associated with miscarriages and stillbirths
  • Dexamethasone associated, from age 16 years, with disturbed insulin secretion and higher glucose and cholesterol levels
  • 15 eligible studies plus 7 records added through references

Original publication

Safety of Antenatal Predniso(lo)ne and Dexamethasone on Fetal, Neonatal and Childhood Outcomes: A Systematic Review. J Clin Endocrinol Metab. Published 16 September 2023. doi:10.1210/clinem/dgad547

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.